Meet the Team

Consistent and frequent physical therapy is one of the few currently available treatments that’s been proven to provide benefits at all ages with the potential to delay disease progression. However, traditional […]

Edgewise Therapeutics, which received early funding from CureDuchenne, announced positive 6-month interim results from the ongoing ARCH study, an open label study of EDG-5506 in adults with Becker muscular dystrophy. Edgewise […]